{"DataElement":{"publicId":"2722907","version":"1","preferredName":"Cytogenetics FLT3 Gene Abnormality Type","preferredDefinition":"the type of genetic abnormality at the chromosomal level of gene that plays a role in hematopoiesis and may function as a growth factor receptor.","longName":"CYTO_FLT3G_ABN_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2722900","version":"1","preferredName":"Cytogenetics FLT3 Gene Abnormality","preferredDefinition":"information related to genetic abnormality at the chromosomal level of gene that plays a role in hematopoiesis and may function as a growth factor receptor.","longName":"CYTOGEN_FLT3GENE_ABN","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2320498","version":"1","preferredName":"Cytogenetics","preferredDefinition":"Cytogenetics is the study of chromosomes and the related disease states caused by numerical and structural chromosome abnormalities.","longName":"C16487","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetics","conceptCode":"C16487","definition":"The branch of biology that studies the cellular aspects of heredity, especially the chromosomes. Includes the study of disease states caused by numerical and structural chromosome abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC71B93E-049D-5AD9-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2722898","version":"1","preferredName":"FLT3 Gene Abnormality","preferredDefinition":"This gene plays a role in hematopoiesis and may function as a growth factor receptor.:A condition that differs from the usual physical or mental state.","longName":"C24399:C9440","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FLT3 Gene","conceptCode":"C24399","definition":"This gene plays a role in hematopoiesis and may function as a growth factor receptor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Abnormality","conceptCode":"C9440","definition":"A condition that differs from the usual physical or mental state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"443C95ED-A168-166B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-21","endDate":null,"createdBy":"ALAIS","dateCreated":"2008-01-21","modifiedBy":"ONEDATA","dateModified":"2008-01-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"443C95ED-A179-166B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-21","endDate":null,"createdBy":"ALAIS","dateCreated":"2008-01-21","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2722901","version":"1","preferredName":"Cytogenetics FLT3 Gene Abnormality Type","preferredDefinition":"the type of mutation in activating class III receptor tyrosine kinase.","longName":"CYTO_FLT3G_ABN_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"40","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"FLT3 TKD","valueDescription":"FLT3 Tyrosine Kinase Domain Point Mutation","ValueMeaning":{"publicId":"2722903","version":"1","preferredName":"FLT3 Tyrosine Kinase Domain Point Mutation","longName":"2722903","preferredDefinition":"Single nucleotide mutations in the tyrosine kinase domain encoded by the human FLT3 gene that are associated with acute myeloid leukemia and poor prognosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FLT3 Tyrosine Kinase Domain Point Mutation","conceptCode":"C67495","definition":"Single nucleotide mutations in the tyrosine kinase domain encoded by the human FLT3 gene that are associated with acute myeloid leukemia and poor prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"443CA9B6-A7E5-1AE7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALAIS","dateCreated":"2008-01-21","modifiedBy":"COLBERTM","dateModified":"2019-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"443CA9B6-A7FE-1AE7-E044-0003BA3F9857","beginDate":"2008-01-21","endDate":null,"createdBy":"ALAIS","dateCreated":"2008-01-21","modifiedBy":"ALAIS","dateModified":"2008-01-21","deletedIndicator":"No"},{"value":"ITD Allelic Ratio < 0.7","valueDescription":"Internal Tandem Duplication (ITD) Allelic Ratio < 0.7","ValueMeaning":{"publicId":"2722908","version":"1","preferredName":"Internal Tandem Duplication (ITD) Allelic Ratio < 0.7","longName":"2722908","preferredDefinition":"FLT3 Internal Tandem Duplication Allelic (ITD)Ratio < 0.7","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"443CBC7B-417C-1CEB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-21","endDate":null,"createdBy":"ALAIS","dateCreated":"2008-01-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"443CBE8F-2379-1DBA-E044-0003BA3F9857","beginDate":"2008-01-21","endDate":null,"createdBy":"ALAIS","dateCreated":"2008-01-21","modifiedBy":"ONEDATA","dateModified":"2008-01-21","deletedIndicator":"No"},{"value":"ITD Allelic Ratio => 0.7","valueDescription":"Internal Tandem Duplication (ITD) Allelic Ratio => 0.7","ValueMeaning":{"publicId":"2722909","version":"1","preferredName":"Internal Tandem Duplication (ITD) Allelic Ratio => 0.7","longName":"2722909","preferredDefinition":"FLT3 Internal Tandem Duplication (ITD) Allelic Ratio => 0.7   ","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"443CC219-7B6C-1FD1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-21","endDate":null,"createdBy":"ALAIS","dateCreated":"2008-01-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"443CC411-FF5E-1D3D-E044-0003BA3F9857","beginDate":"2008-01-21","endDate":null,"createdBy":"ALAIS","dateCreated":"2008-01-21","modifiedBy":"ONEDATA","dateModified":"2008-01-21","deletedIndicator":"No"},{"value":"No FLT3 gene mutation","valueDescription":"No FLT3 gene mutation","ValueMeaning":{"publicId":"2722910","version":"1","preferredName":"No FLT3 gene mutation","longName":"2722910","preferredDefinition":"No FLT3 gene mutation","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"443CB649-A437-1D3B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-21","endDate":null,"createdBy":"ALAIS","dateCreated":"2008-01-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"443CC791-AE48-1658-E044-0003BA3F9857","beginDate":"2008-01-21","endDate":null,"createdBy":"ALAIS","dateCreated":"2008-01-21","modifiedBy":"ONEDATA","dateModified":"2008-01-21","deletedIndicator":"No"},{"value":"FLT3  ITD","valueDescription":"FLT3 Internal Tandem Duplication","ValueMeaning":{"publicId":"3630974","version":"1","preferredName":"FLT3 Internal Tandem Duplication","longName":"3630974","preferredDefinition":"A genetic abnormality that arises from duplications of the juxtamembrane portion of the gene and results in constitutive activation of the FLT3 receptor tyrosine kinase protein in early hematopoietic progenitor cells. It is associated with acute myelogenous leukemia where it appears to correlate with a poor prognosis.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FLT3 Internal Tandem Duplication","conceptCode":"C67494","definition":"A genetic abnormality that arises from duplications of the juxtamembrane portion of the gene and results in constitutive activation of the FLT3 receptor tyrosine kinase protein in early hematopoietic progenitor cells. It is associated with acute myelogenous leukemia where it appears to correlate with a poor prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CF94B6E0-9B06-7FAD-E040-BB89AD433160","latestVersionIndicator":"Yes","beginDate":"2012-11-28","endDate":null,"createdBy":"LEUNGE","dateCreated":"2012-11-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF94B6E0-9B1E-7FAD-E040-BB89AD433160","beginDate":"2012-11-28","endDate":null,"createdBy":"LEUNGE","dateCreated":"2012-11-28","modifiedBy":"ONEDATA","dateModified":"2012-11-28","deletedIndicator":"No"},{"value":"Not available at registration","valueDescription":"Not available at registration","ValueMeaning":{"publicId":"3631554","version":"1","preferredName":"Not available at registration","longName":"3631554","preferredDefinition":"FLT3 value not available at study enrollment (if allowed by study protocol)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFA750DB-7DA7-B964-E040-BB89AD434570","latestVersionIndicator":"Yes","beginDate":"2012-11-29","endDate":null,"createdBy":"LEUNGE","dateCreated":"2012-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","id":"CFA750DB-7DC0-B964-E040-BB89AD434570","beginDate":"2012-11-29","endDate":null,"createdBy":"LEUNGE","dateCreated":"2012-11-29","modifiedBy":"ONEDATA","dateModified":"2012-11-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"443CA9AA-D041-1969-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-21","endDate":null,"createdBy":"ALAIS","dateCreated":"2008-01-21","modifiedBy":"LEUNGE","dateModified":"2012-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811909","version":"1","longName":"Leukemia","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811957","version":"1","longName":"Labs","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"10000362","version":"1","longName":"AML Prev Untreated","context":"CTEP"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811890","version":"1","longName":"Phase III","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Results","type":"Preferred Question Text","description":"Results","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"FLT3 Gene Mutation Status","url":null,"context":"CTEP"}],"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"443CB173-AB96-1C46-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-21","endDate":null,"createdBy":"ALAIS","dateCreated":"2008-01-21","modifiedBy":"LEUNGE","dateModified":"2012-11-28","changeDescription":"For use in CALGB leukemia OPEN registration worksheets","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}